2.30

1.92% -0.045

Sunshine Biopharma Inc (SBFM)

Overview News Price History Financials Discussions Forecast Stock Split

Sunshine Biopharma Inc stock is traded at $2.30, with a volume of 50,863. It is down -1.92% in the last 24 hours and down -23.59% over the past month. Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.

Previous Close:

$2.345

Open:

$2.34

24h Volume:

50,863

Relative Volume:

0.31

Market Cap:

$4.56M

Revenue:

$24.09M

Net Income/Loss:

$-4.51M

P/E Ratio:

-1.369

EPS:

-1.68

Net Cash Flow:

$-9.56M

1W Performance:

-11.88%

1M Performance:

-23.59%

6M Performance:

-87.63%

1Y Performance:

-99.57%

1-Day Range:

$2.27

$2.38

1-Week Range:

$2.25

$2.73

52-Week Range:

$2.25

$637.20

Sunshine Biopharma Inc Stock (SBFM) Company Profile

Name

Sunshine Biopharma Inc

Sector

Healthcare (1200)

Industry

Drug Manufacturers - Specialty & Generic (87)

Phone

954-515-0810

Address

333 LAS OLAS WAY, FORT LAUDERDALE

Employee

Twitter

Next Earnings Date

2024-11-11

Latest SEC Filings

SBFM's Discussions on Twitter

Compare SBFM with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SBFM	2.29	4.56M	24.09M	-4.51M	-9.56M	-1.68
ZTS	176.38	79.52B	9.15B	2.43B	2.31B	4.92
TAK	13.56	43.13B	30.27B	1.93B	3.45B	0.444
HLN	9.425	42.57B	14.26B	1.55B	0	0.3327
TEVA	16.45	18.56B	16.77B	-959.00M	1.37B	-2.00
VTRS	13.00	15.37B	15.24B	-646.50M	1.88B	1.53

Sunshine Biopharma Inc Stock (SBFM) Latest News

Nov 12, 2024

Sunshine Biopharma Inc. Warrant (SBFMW) Quarterly 10-Q Report - Quartz

Nov 12, 2024

Nov 06, 2024

Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54% - AccessWire

Nov 06, 2024

Sunshine Biopharma Q3 Revenue Surges 42% to $8.4M Despite Widening Losses | SBFM Stock News - StockTitan

Nov 06, 2024

SBFM (Sunshine Biopharma) Shares Outstanding (EOP) : 1.17 Mil (As of Jun. 2024) - GuruFocus.com

Nov 06, 2024

Oct 31, 2024

Canopy Growth Corporation (CGC) Stock Declines Amid Financial Re - GuruFocus.com

Oct 31, 2024

Oct 29, 2024

Bloomin’ Brands (NASDAQ:BLMN) Rating Increased to Hold at StockNews.com - Defense World

Oct 29, 2024

StockNews.com Begins Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World

Oct 29, 2024

DBV Technologies (NASDAQ:DBVT) Research Coverage Started at StockNews.com - Defense World

Oct 29, 2024

JATT Acquisition (NYSE:JATT) Trading Down 2.7% – Should You Sell? - Defense World

Oct 29, 2024

Oct 23, 2024

Sunshine Biopharma Strengthens Leadership with New Executive Agreements - TipRanks

Oct 23, 2024

Oct 16, 2024

Elanco Animal Health (ELAN) Stock Drops 5% Amidst Industry Decli - GuruFocus.com

Oct 16, 2024

Oct 12, 2024

Sunshine Biopharma, Inc. (NASDAQ:SBFM) Short Interest Up 66.8% in September - MarketBeat

Oct 12, 2024

Sep 26, 2024

Sunshine Biopharma announces Nora Pharma launch of two new generic drugs - TipRanks

Sep 26, 2024

Sunshine Biopharma expands generic drug portfolio - Investing.com

Sep 26, 2024

Sunshine Biopharma’s Nora Pharma launches two generic prescription drugs - TipRanks

Sep 26, 2024

Sunshine Biopharma Launches Two New Generic Prescription Drugs - AccessWire

Sep 26, 2024

Sep 23, 2024

A new trading data show Sunshine Biopharma Inc (SBFM) is showing positive returns. - SETE News

Sep 23, 2024

Sep 19, 2024